Skip to search formSkip to main contentSkip to account menu

Etidronate

Known as: 1,1 hydroxyethylenediphosphonate, 1 Hydroxyethylidene 1,1 Bisphosphonate, 1-Hydroxy-1,1-diphosphonoethane 
National Institutes of Health

Related topics

Related topics

12 relations

Narrower (2)

DidronelETIDRONATE TETRASODIUM
DiphosphonatesDrug AllergyEtidronate DisodiumHeterotopic Ossification

Broader (3)

Etidronic Acidalkylphosphatecalcification inhibitor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Bisphosphonates in multiple myeloma.
BACKGROUND Bisphosphonates are specific inhibitors of osteoclastic activity and are currently used as supportive therapy for… 
Review
1996
Review
1996
Medical Heuristics: The Silent Adjudicators of Clinical Practice
Medicine has avoided facing a harsh reality. Although we assume that medical decisions are driven by established scientific fact… 
Highly Cited
1995
Highly Cited
1995
A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.
Highly Cited
1993
Highly Cited
1993
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
PURPOSE To determine the effect of long-term intermittent cyclic etidronate treatment on spinal bone density and vertebral… 
Highly Cited
1991
Highly Cited
1991
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
Rhenium-186 (tin) hydroxyethylidene diphosphonate (HEDP) is a new radiopharmaceutical that simultaneously localizes in multiple… 
Highly Cited
1990
Highly Cited
1990
Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.
Bisphosphonates are useful in treatment of disorders with increased osteoclastic activity, but the mechanism by which… 
Highly Cited
1978
Highly Cited
1978
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
The limited role of bone scanning in the diagnosis of metabolic bone disease might be considerably improved by accurate… 
Highly Cited
1975
Highly Cited
1975
Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Methylene diphosphonate (MDP) was formulated as a complex of 99mTc for skeletal imaging. This agent was compared with three other… 
Highly Cited
1975
Highly Cited
1975
Observations on the induction of bone in soft tissues.
Using bone decalcified with 0-6 N hydrochloric acid as an inducing agent, the inductive capacity of different soft tissue sites… 
Highly Cited
1973
Highly Cited
1973
Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)